Ophthalmology · Flint, MI
NPI
1205046331
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1160 S Linden Rd
Flint, MI, 48532
Phone (810) 820-8230
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
2,003 services
Medicare patients, 2024
319
Average age 76
Drug cost, 2024
$690K
5,632 prescriptions
Company payments, 2025
$946
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aman K Shukairy was code 99214 (office e&m - established), 406 times for 239 patients. In total Aman K Shukairy billed 2,003 services in 33 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 406 | 239 | $80.25 | $33K |
| 92083 Vision, Hearing, and Speech Services | Office | 396 | 257 | $40.91 | $16K |
| 92250 Angiography | Office | 249 | 237 | $21.73 | $5,410 |
| 92133 Computerized Ophthalmic Imaging | Office | 233 | 222 | $22.44 | $5,229 |
| 99213 Office E&M - Established | Office | 170 | 128 | $62.03 | $11K |
| 92014 Ophthalmological E&M | Office | 102 | 80 | $78.51 | $8,008 |
| 92136 Ultrasound - Nonspecific | Office | 65 | 47 | $31.92 | $2,075 |
| 99204 Office E&M - New | Office | 60 | 60 | $93.85 | $5,631 |
| 66984 Cataract Surgery | Facility | 57 | 38 | $333.51 | $19K |
| 76514 Ultrasound - Nonspecific | Office | 55 | 54 | $7.90 | $434 |
| 66821 Cataract Surgery | Facility | 48 | 31 | $221.02 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 36 | 36 | $12.70 | $457 |
| 65820 Fluid Flow and Drainage of Eye (Any Method) | Facility | 18 | 13 | $601.80 | $11K |
By year: 2022 $137K for 1,874 services; 2023 $149K for 1,949 services; 2024 $148K for 2,003 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aman K Shukairy prescribed most often to Medicare patients was Latanoprost, with 1,449 prescriptions and refills. In total Aman K Shukairy wrote 5,632 Medicare prescriptions that cost $690K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,449 | 3,445 | 459 | $35K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 706 | 1,384 | 178 | $19K |
| Timolol Maleate Generic | 675 | 1,601 | 232 | $14K |
| Brimonidine Tartrate Generic | 479 | 969 | 144 | $21K |
| Lumigan Bimatoprost | 339 | 731 | 110 | $181K |
| Prednisolone Acetate Generic | 310 | 331 | 171 | $10K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 262 | 566 | 75 | $78K |
| Ketorolac Tromethamine Generic | 248 | 261 | 153 | $3,688 |
| Ofloxacin Generic | 240 | 242 | 145 | $2,721 |
| Dorzolamide Hcl Generic | 213 | 430 | 70 | $5,516 |
| Rhopressa Netarsudil Mesylate | 91 | 188 | 30 | $59K |
| Vyzulta Latanoprostene Bunod | 86 | 152 | 26 | $46K |
| Combigan Brimonidine Tartrate/Timolol | 80 | 131 | 20 | $30K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 52 | 81 | 18 | $27K |
| Cyclosporine Generic | 51 | 132 | 20 | $31K |
Brand drugs: 1,451 claims; generic drugs: 4,181 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aman K Shukairy $946 ($946 in general payments such as food, travel and fees) from 15 companies. The largest payer was Sight Sciences, Inc. with $208.
| Company | Payments | Amount |
|---|---|---|
| Sight Sciences, Inc. SGHT | 9 | $208 |
| Alcon Vision LLC ALC | 4 | $193 |
| Abbvie Inc. ABBV | 8 | $157 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $70.38 |
| Glaukos Corporation GKOS | 1 | $46.81 |
| Nova Eye, Inc. | 1 | $43.88 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $39.78 |
| Biotissue Holdings Inc. | 2 | $37.97 |
| Dompe US, Inc. | 2 | $33.28 |
| Harrow Eye, LLC | 1 | $29.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.